Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Hematology/Oncology Clinics of North America|May 16, 2022
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal CancerMidhun Malla, Aparna R ParikhJournal of the National Comprehensive Cancer Network : JNCCN|December 16, 2024
ctDNA/MRD Testing for Colon Cancer: A Work in Progress or Ready for Prime-Time Standard of Care?Bennett A Caughey, Aparna R ParikhCancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B CorcoranCancers|July 9, 2022
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)Sakti Chakrabarti, Anup Kumar Kasi, Aparna R Parikh, et al.Cureus|June 28, 2022
Organ Preservation in Colon Cancer: An Illustrative Case ReportKruti B Vora, Sameer Tolay, Aparna R Parikh, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor LocationAnurag Saraf, Hannah J Roberts, Jennifer Y Wo, et al.The Oncologist|November 12, 2024
Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancerLeontios Pappas, Julia C F Quintanilha, Richard S P Huang, et al.Healthcare (Basel, Switzerland)|December 8, 2023
Recent Advances in the Management of Anal CancerLaxmi Upadhyay, Michelle Hartzell, Aparna R Parikh, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 20, 2024
Guiding Principles for Community Building in Global OncologyInas Abuali, Aju Mathew, Eulade Rugengamanzi, et al.Journal for Immunotherapy of Cancer|August 24, 2019
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse eventsYousef R Badran, Justine V Cohen, Priscilla K Brastianos, et al.Pageof 8